Cargando…
Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles
Currently, therapy for thyroid cancer mainly involves surgery and radioiodine therapy. However, chemotherapy can be used in advanced and aggressive thyroid cancer that cannot be treated by other options. Nevertheless, a major obstacle to the successful treatment of thyroid cancer is the delivery of...
Autores principales: | Li, Shijie, Zhang, Daqi, Sheng, Shihou, Sun, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573063/ https://www.ncbi.nlm.nih.gov/pubmed/28860762 http://dx.doi.org/10.2147/IJN.S137335 |
Ejemplares similares
-
Silicon dioxide nanoparticles decorated on graphene oxide nanosheets and their application in poly(l-lactic acid) scaffold
por: Shuai, Cijun, et al.
Publicado: (2022) -
Biocompatibility of cerium dioxide and silicon dioxide nanoparticles with endothelial cells
por: Strobel, Claudia, et al.
Publicado: (2014) -
Apurinic/apyrimidinic endonuclease triggered doxorubicin-releasing DNA nanoprism for target therapy
por: Liang, Meng, et al.
Publicado: (2022) -
Hyaluronic acid–doxorubicin nanoparticles for targeted treatment of colorectal cancer
por: Pan, Daniel C., et al.
Publicado: (2020) -
Excimer Formation in Carboxylic Acid-Functionalized
Perylene Diimides Attached to Silicon Dioxide Nanoparticles
por: Gorman, Jeffrey, et al.
Publicado: (2019)